Mission and Vision

“Our mission is to discover and develop genetic and biologic tools that will have direct clinical applicability for a better diagnosis, prognosis and treatment of patients with myeloma, light chain amyloidosis,Waldenström macroglobulinemia and associated disorders.”

“Our vision is to be the premier translational laboratory capable of integrating, understanding and validating the clinical utility of genetic and other biomarkers.  We also aspire to be a premier center of translating the knowledge attained via this process into useful treatment strategies"